InvestorsObserver
×
News Home

Can Gilead Sciences, Inc. (GILD) Stock Rise to the Top of Healthcare Sector Monday?

Monday, March 20, 2023 11:36 AM | InvestorsObserver Analysts

Mentioned in this article

Can Gilead Sciences, Inc. (GILD) Stock Rise to the Top of Healthcare Sector Monday?

A rating of 96 puts Gilead Sciences, Inc. (GILD) near the top of the Healthcare sector according to InvestorsObserver. Gilead Sciences, Inc.'s score of 96 means that it ranks higher than 96% of stocks in the sector. In addition, its overall score of 80 ranks it higher than 80% of all stocks.

Overall Score - 80
GILD has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on GILD!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Gilead Sciences, Inc. Stock Today?

Gilead Sciences, Inc. (GILD) stock is trading at $78.71 as of 11:26 AM on Monday, Mar 20, an increase of $1.40, or 1.81% from the previous closing price of $77.31. The stock has traded between $77.63 and $79.22 so far today. Volume today is less active than usual. So far 1,035,274 shares have traded compared to average volume of 6,486,615 shares. Click Here to get the full Stock Report for Gilead Sciences, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App